ARTG 402300DemeQUICK - Suture, polyglactin
ARTG ID: 402300 · Avacare Australia Pty Ltd · DemeTECH Corp · Class III · Started January 17, 2023
Good Name: Avacare Australia Pty Ltd - DemeQUICK - Suture, polyglactin
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 402300
- Start Date
- January 17, 2023
- Effective Date
- January 17, 2023
- Name
- DemeTECH Corp
- Country
- United States of America
- Address
- 14175 NW 60th Avenue, Miami Lakes, FL, 33014
DemeQUICK (Rapid Absorbable) Surgical Suture is indicated for use in superficial soft tissue approximation (i.e., mucosa and skin) where only short term wound support (7-10 days) is required. DemeQUICK (Rapid Absorbable) Surgical Suture is not intended for use in ligation, cardiovascular, ophthalmic or neurological procedures.
Access comprehensive regulatory information for DemeQUICK - Suture, polyglactin in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 402300 and sponsored by Avacare Australia Pty Ltd, manufactured by DemeTECH Corp in United States of America. The device registration started on January 17, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.